Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ: ILMN )

100.24 -1.54 (-1.51%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
The Benzinga Stock Whisper highlights five stocks seeing increased interest across the Benzinga ecosystem using proprietary data. 
Via Benzinga
3 Precision Medicine Stocks Tailoring Treatments
With technological developments pushing the boundaries of healthcare, these are the precision medicine stocks to consider. 
Via InvestorPlace
$1000 Invested In Illumina 20 Years Ago Would Be Worth This Much Today
Via Benzinga
Strategic Buy Lights Up This Biotech Stock: Time to Invest?
Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences. 
Via MarketBeat
3 Spinoff Stocks You Should Buy Now: July 2024
Spinoff stocks often take time to gain their footing in the market giving investors an opportunity to get in early. 
Via InvestorPlace
Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years
Via Benzinga
A Glimpse Into The Expert Outlook On Illumina Through 10 Analysts
Via Benzinga
What's Going On With 10x Genomics Stock On Wednesday?
Illumina acquires Fluent BioSciences to enhance single-cell analysis and multiomics research. 10x Genomics faces challenges as shares drop amid competitive pricing pressures in the single-cell market. 
Via Benzinga
Illumina Buys Fluent BioSciences To Gain Stronger Foothold In Single-Cell Analysis
Illumina has acquired Fluent BioSciences, enhancing its single-cell analysis and multiomics capabilities. Fluent's innovative technology, including the PIPseq V system, offers cost-effective and... 
Via Benzinga
SMART Global Posts Upbeat Results, Joins Aehr Test Systems, MarineMax And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
3 Of the Best ETFs to Buy for AI Stocks Exposure
One of the best ways to gain max exposure to the unstoppable artificial intelligence boom is with popular AI ETFs. 
Via InvestorPlace
Topics Artificial Intelligence ETFs
Exposures Artificial Intelligence
The 3 Best Gene Editing Stocks to Buy in July 2024
Gene editing is revolutionizing medicine, creating substantial opportunities for some of the best gene editing stocks. 
Via InvestorPlace
3 Biotech Stocks Turning DNA Dreams Into Dollars
Investors should consider buying into one of the future avenues of medicine by investing in these three BNA biotech stocks. 
Via InvestorPlace
The 3 Best Personalized Medicine Stocks to Buy in July 2024
Explore promising personalized medicine stocks poised for growth as the industry expands, driven by advancements in genomic technologies. 
Via InvestorPlace
GRAL Stock Alert: 7 Things to Know as Grail Starts Trading Today
New biotech stock Grail begins trading on the Nasdaq today. Here's what investors need to know about GRAL stock. 
Via InvestorPlace
Once Valued At Around $7B, Cancer Blood Test Developer Grail To Kickstart Trading On NASDAQ
Illumina spins off Grail, making Grail an independent public company. Shareholders receive one GRAIL share per six Illumina shares. Illumina retains a 14.5% stake. 
Via Benzinga
Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers Over The Past 12 Months - Sunday, June 23
Over the past twelve months, 10 large-cap stocks have underperformed all others. Here's a brief look at these underperforming stocks. 
Via Talk Markets
3 Stocks to Buy That Are NOT in the S&P 500 (but Should Be)
Companies not yet in the S&P 500 but whose businesses are doing well make excellent stocks to buy. Here are three examples. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Meet the Newest Artificial Intelligence (AI) Stock in the S&P 500. It's Up 266% Since Last Year, and Wall Street Says It's Still a Buy Today
The cybersecurity leader is building on existing advantages using AI innovations. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
The Watchlist: 3 Stock Spinoffs Coming Soon (Be Ready to Buy)
These stock spinoffs to buy represent opportunities to gain a foothold in businesses that were previously lost when competing for resources. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Meet the Newest Artificial Intelligence (AI) Stock in the S&P 500. It Ranks Among the Fastest-Growing Enterprise Software Companies.
Cybersecurity specialist CrowdStrike will join the S&P 500 on June 24. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
Amazon, Natera And A Financial Stock: CNBC's 'Final Trades'
The recommendation comes after a former Amazon employee accused the Seattle-based company of selling technology to Russia. 
Via Benzinga
Here's Why Stocks Such as CrowdStrike and KKR Jumped Today, Whereas Stocks Such as Illumina Dropped
The S&P 500 is changing yet again. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
KKR Stock Pops 10% on June 21 Inclusion in the S&P 500
KRR stock is up on Monday after investors learned that the shares are being added to the S&P 500 as part of its quarterly reblance. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
GDDY Stock Alert: GoDaddy Will Join the S&P 500 on June 21
GoDaddy stock is up on Monday as GDDY investors celebrate the company joining the S&P 500 later this month on an index rebalance. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Palantir Was Left Out of the S&P 500; It Still Looks Like a Buy
Palantir stock dropped about 2% after news that it will not be added to the S&P 500, but despite the short-term setback, PLTR is still a solid long-term buy 
Via MarketBeat
Topics Stocks
Exposures US Equities
CrowdStrike Holdings Stock Is Surging Monday: What's Going On?
S&P Dow Jones Indices announced that CrowdStrike, KKR & Co and GoDaddy would replace Robert Half, Comerica and Illumina in the S&P 500. The changes are set to become effective prior to the open of... 
Via Benzinga
Topics Stocks
Exposures US Equities
Arm And Boeing Were Among 10 Large Cap Stocks That Shined The Brightest Last Week (June 1-June 7, 2024): Are They In Your Portfolio?
Top performing large-cap stocks in the past week include GME, GWRE, RDDT, SAIA, PLTR, GFL, COIN, ILMN, CRWD, and ESTC. 
Via Benzinga
Cybersecurity Provider CrowdStrike And These 2 Companies Make The Cut For S&P 500 Inclusion, Palantir Misses Out Yet Again
Palantir was once again overlooked, while an asset manager and two tech companies were deemed worthy of being added to the prestigious index. 
Via Benzinga
Topics Stocks
Exposures US Equities
< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.